Document is current
Any future updates will be listed below
-
Authors
Johnsson, Kerstin
Brynolfsson, Johan
Sahlstedt, Hannicka
Nickols, Nicholas G.
Rettig, Matthew
Probst, Stephan
Morris, Michael J.
Bjartell, Anders
Eiber, Mathias
Anand, Aseem http://orcid.org/0000-0001-9452-6094
-
Funding
Funding for this research was provided by:
EXINI Diagnostics
Lund University
- License Information
-
More Information
Article History
Received: 12 May 2021
Accepted: 9 July 2021
First Online: 31 August 2021
Change Date: 13 August 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: The phase III OSPREY study (NCT02981368) received approval of institutional review boards of the ten respective institutions in the USA and Canada. The ethical permission for the Principal Investigated – Research Access Program (IND #121064) was obtained from the institutional review board at the Jewish General Hospital, Montreal, Canada, and at the John Hopkins Hospital, Baltimore, MD, USA.
: All patients were consented to participate in the OSPREY and Research Access Program.
: All authors have given their consent for publication.
: Drs A. Anand, J. Brynolfsson, K. Johnsson, and MSc H. Sahlstedt are employees of EXINI Diagnostics AB. All other authors have no conflict to declare related to the submitted work.
